Reginald Seeto - 25 Jun 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
President & Chief Executive Officer, Director
Signature
/s/ Reginald Seeto
Issuer symbol
CDNA
Transactions as of
25 Jun 2021
Net transactions value
-$1,242,378
Form type
4
Filing time
17 Aug 2021, 18:59:14 UTC
Previous filing
25 Jun 2021
Next filing
07 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $79,064 +3,247 +2.5% $24.35 135,618 25 Jun 2021 Direct F1
transaction CDNA Common Stock Options Exercise $165,294 +5,963 +4.4% $27.72 141,581 25 Jun 2021 Direct F1
transaction CDNA Common Stock Sale $876,318 -9,210 -6.5% $95.15 132,371 25 Jun 2021 Direct F1, F2
transaction CDNA Common Stock Options Exercise $37,621 +1,545 +1.2% $24.35 133,916 28 Jun 2021 Direct F1
transaction CDNA Common Stock Options Exercise $316,992 +11,667 +8.7% $27.17 145,583 28 Jun 2021 Direct F1
transaction CDNA Common Stock Sale $813,150 -8,522 -5.9% $95.42 137,061 28 Jun 2021 Direct F1, F3
transaction CDNA Common Stock Sale $451,841 -4,690 -3.4% $96.34 132,371 28 Jun 2021 Direct F1, F4
transaction CDNA Common Stock Options Exercise $299,958 +10,821 +8.2% $27.72 143,192 11 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -3,247 -9.2% $0.000000 31,961 25 Jun 2021 Common Stock 3,247 $24.35 Direct F1, F5
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -5,963 -8.2% $0.000000 66,869 25 Jun 2021 Common Stock 5,963 $27.72 Direct F1, F6
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -1,545 -4.8% $0.000000 30,416 28 Jun 2021 Common Stock 1,545 $24.35 Direct F1, F5
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -11,667 -45% $0.000000 14,500 28 Jun 2021 Common Stock 11,667 $27.17 Direct F1, F7
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -10,821 -16% $0.000000 56,048 11 Aug 2021 Common Stock 10,821 $27.72 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $90.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $96.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.10 to $96.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F5 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.
F6 25% of the shares subject to the option vested on November 26, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F7 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.

Remarks:

President & Chief Executive Officer